| Written | 2017-11 | Adriana Zamecnikova |
| Kuwait Cancer Control Center, Kuwait annaadria@yahoo.com |
| Abstract | Review on t(11;14)(q11;q32), with data on clinics, and the genes involved. |
| Keywords | Immunoglobulin translocations, B-cell lymphoproliferative malignancies, multiple myeloma, gene overexpression |
| Identity |
| ICD-Topo | C420,C421,C424 |
| ICD-Morpho | 9823/3 Chronic lymphocytic leukaemia /small lymphocytic lymphoma |
| ICD-Morpho | 9733/3 |
| ICD-Morpho | 9673/3 Mantle cell lymphoma |
| ICD-Morpho | 9732/3 Plasma cell myeloma / Multiple myeloma |
| Atlas_Id | 1806 |
| Clinics and Pathology |
| Disease | B-cell lymphoid malignancies and multiple myeloma. |
| Etiology | B-cell lymphoid malignancies in 5: 3 chronic lymphocytic leukemia (CLL) (Schroder et al., 1981; Weisenburger et al., 1987; Bird et al., 1989), 1 plasma cell leukemia (PCL) (Ueshima et al., 1983), 1 mantle cell lymphoma (MCL) (Espinet et al., 1999) and 2 multiple myeloma (MM) patients (Sawyer et al., 1995; Gozzetti et al., 2011). |
| Epidemiology | 2 males and 5 females aged 45 to 78 years, median 63 years. |
| Prognosis | Chromosome 14q32 translocations that are part of complex karyotypes are associated with an adverse prognosis in B-cell malignancies. |
| Cytogenetics |
| Note | The breakpoint on chromosome 11 is 11q13 in the most common t(11;14)(q13;32), therefore some of the translocations described as t(11;14)(q11;q32) in early reports may involve 11q13 breakpoint. |
| Additional anomalies | Found in association with highly complex karyotypes, thus it is unclear if t(11;14)(q11;q32) was a primary aberration in these patients or it appeared as a secondary change during karyotypic progression. |
| Genes involved and Proteins |
| Gene Name | IGH (Immunoglobulin Heavy Locus) |
| Location | 14q32.33 |
| Note | IGH translocations relocate genes near active regulatory sequences of the partner gene, resulting in their overexpression. |
| Result of the chromosomal anomaly |
| Oncogenesis | Translocations involving chromosome 14 at band q32, at the site of the immunoglobulin heavy chain (IGH) locus have been described in a spectrum of B-cell malignancies. In these translocations, various partner chromosomes have been described, including chromosome 11, of which the t(11;14)(q13;q32) that leads to the overexpression of the CCND1 gene is the most common. Chromosome translocations involving centromeric 11q breakpoints are less frequent and have been described only in sporadic cases of B-cell lymphoid malignancies and multiple myeloma. Although the mechanism of neoplastic transformation remains unknown, deregulation of the translocated partner gene as a consequence of its transposition into the IGH locus may represent a mechanism of oncogene activation. |
| To be noted |
| Additional cases are needed to delineate the epidemiology of this rare entity: you are welcome to submit a paper to our new Case Report section. |
| Bibliography |
| Chromosome abnormalities in B cell chronic lymphocytic leukemia and their clinical correlations |
| Bird ML, Ueshima Y, Rowley JD, Haren JM, Vardiman JW |
| Leukemia 1989 Mar;3(3):182-91 |
| PMID 2918755 |
| Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma |
| Espinet B, Solé F, Woessner S, Bosch F, Florensa L, Campo E, Costa D, Lloveras E, Vilà RM, Besses C, Montserrat E, Sans-Sabrafen J |
| Cancer Genet Cytogenet 1999 May;111(1):92-8 |
| PMID 10326598 |
| A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report |
| Gozzetti A, Cerase A, Crupi R, Raspadori D, Defina M, Bocchia M, Lauria F |
| Leuk Res 2011 Nov;35(11):e206-8 |
| PMID 21767877 |
| Cytogenetic findings in 200 patients with multiple myeloma |
| Sawyer JR, Waldron JA, Jagannath S, Barlogie B |
| Cancer Genet Cytogenet 1995 Jul 1;82(1):41-9 |
| PMID 7627933 |
| Chromosome changes in human chronic lymphocytic leukemia |
| Schröder J, Vuopio P, Autio K |
| Cancer Genet Cytogenet 1981 Aug;4(1):11-21 |
| PMID 6974590 |
| Cytogenetic studies and clinical aspects of patients with plasma cell leukemia and leukemic macroglobulinemia |
| Ueshima Y, Fukuhara S, Nagai K, Takatsuki K, Uchino H |
| Cancer Res 1983 Feb;43(2):905-12 |
| PMID 6401225 |
| Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings |
| Weisenburger DD, Sanger WG, Armitage JO, Purtilo DT |
| Blood 1987 Jun;69(6):1617-21 |
| PMID 3555648 |
| Citation |
| This paper should be referenced as such : |
| Adriana Zamecnikova |
| t(11;14)(q11;q32) |
| Atlas Genet Cytogenet Oncol Haematol. 2019;23(2):36-37. |
| Free journal version : [ pdf ] [ DOI ] |
| On line version : http://AtlasGeneticsOncology.org/Anomalies/t1114q11q32ID1806.html |
| Translocations implicated (Data extracted from papers in the Atlas) |
| t(11;14)(q11;q32) ?/IGH | |
| External links |
| REVIEW articles | automatic search in PubMed |
| Last year articles | automatic search in PubMed |
| All articles | automatic search in PubMed |
| © Atlas of Genetics and Cytogenetics in Oncology and Haematology | indexed on : Mon Sep 7 15:08:07 CEST 2020 |
For comments and suggestions or contributions, please contact us